Regulatory
Takumi Pharmaceutical Manufacturing Companies has received official manufacturing and marketing approvals for novel OD tablets and micro-sized solid doses designed to improve elderly patient compliance.

Stay updated on PMDA pharmaceutical approvals, clinical study publications, financial results, and corporate sustainability initiatives from Takumi Group.
Takumi Pharmaceutical Manufacturing Companies has received official manufacturing and marketing approvals for novel OD tablets and micro-sized solid doses designed to improve elderly patient compliance.
Recognition of proactive ESG governance, greenhouse gas decarbonization milestones across manufacturing plants, and expanded gender diversity in executive leadership.
State-of-the-art isolator tableting suites commissioned to expand domestic supply of oral oncology supportive generics and reduce reliance on overseas imported APIs.